IGF1 and breast cancer: The prohibitive effects of CR on breast cancer growth may result from the lowering effects of CR on bioavailable levels of insulin, IGF1, leptin and pro-inflammatory molecules; thus, CR impacts molecular pathways leading to the suppression of cell growth and angiogenesis.